Dr. Markus Goddemeier

Direct Sales of MolecularHealth's Genomic Services to Key Accounts in Germany. By processing NGS information about a patient’s tumor through MolecularHealth’s proprietary knowledge-modeling engine—TreatmentMAP™—our solutions analyze and synthesize extensive bodies of molecular, biomedical, and clinical evidence, mapping results to a patient’s clinical and molecular status and providing a basis for more precise, more efficient, and more safe medicine.